<p>This is a $249,726.25 firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to Memsel Inc., a small disadvantaged business, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for the development of an "Advanced Hydrogel-Based Drug Delivery System for Enhanced Neuroprotection in Traumatic Brain Injuries" and has a period of performance through May 6, 2025. The contract was set aside for small businesses.</p>
This is a $249,999.84 Small Business Innovation Research (SBIR) Phase I contract awarded by the Defense Health Agency (DHA) to Acatechol, Inc., a minority-owned small business located in Pasadena, California. The contract is for the development of "bioinspired chitosan-based hydrogels for neuroprotective treatment for traumatic brain injury" under the DHA SBIR topic DHA242-003. The contract has a performance period ending on October 2, 2025. Acatechol, Inc. is a for-profit...
This is a $1,063,367.96 firm fixed price contract awarded by the Defense Health Agency (DHA) to Mign Inc., a self-certified small disadvantaged business, woman-owned small business, and manufacturer of goods. The contract was awarded under the SBIR (Small Business Innovation Research) program, specifically Phase II, and is titled "REVOLUTIONIZING RECOVERY INNOVATIONS IN DIGITAL DESIGN AND RAPID MANUFACTURING MEDICAL R AND D." The contract has a total small business set-aside...
This $250,000.00 federal contract award to Critical Innovations LLC is for the Defense Health Agency's (DHA) Small Business Innovation Research (SBIR) Phase I project titled "SUCCOR COMBAT FOAM FOR OPEN TRAUMATIC BRAIN INJURY MEDICAL R AND D". The contract is designated as a total small business set-aside and has a firm fixed price pricing type. Critical Innovations, a small business limited liability company, will be responsible for developing an innovative combat foam solution to...
This federal contract award from the Defense Health Agency (DHA) is a Small Business Innovation Research (SBIR) Phase I purchase order to Advanced Life Technologies, LLC for the "ROBOMEDIC" medical research project. The firm-fixed-price contract has a ceiling value of $249,900.26 and an ultimate completion date of May 6, 2025. As an SBIR Phase I award, this contract supports early-stage research and development efforts. The contract is designated as a total small business set-aside,...
This federal contract award was issued by the Defense Health Agency (DHA) to Hybrid Plastics, Incorporated, a for-profit manufacturer, under the Small Business Innovation Research (SBIR) Program Phase II. The contract, valued at $999,997.59, is for the development of a "Hemostatic Agent" under the DHA PHASE II SBIR H2-0265 project. The contract is a Definitive Contract with a Cost Plus Fixed Fee pricing type, and the period of performance is from the award date of September 15, 2017...
This is a firm fixed-price definitive contract awarded by the Defense Health Agency (DHA) to Biomojo LLC, a woman-owned small business, for a SBIR Phase I project titled "NXCOMMS Intelligent Patient Simulation". The contract, valued at $162,499.25, is for research and development services related to computational biology, wearable sensors, data analytics, and artificial intelligence to develop virtual patient simulation tools to support medical training for the Army. Biomojo has...
The federal contract award HT942523D0009|HT942524F0160 was issued to FD Neurotechnologies Consulting & Services, Inc., a minority-owned, self-certified small disadvantaged business, for the provision of histology services. The $47,111.42 fixed-price delivery order was awarded by the Defense Health Agency (DHA), a defense agency, with an ultimate completion date of August 14, 2024. FD Neurotechnologies Consulting & Services, Inc. specializes in providing specialized laboratory services...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of the Army Medical Command to Antiradical Therapeutics LLC, a minority-owned, for-profit limited liability company. The contract, valued at $150,000.00, is for the development of SANFLOW, a therapeutic agent for use in the field to treat traumatic brain injury. The contract is a firm-fixed-price definitive contract and has a completion date of July 24, 2018. The place of performance is in Buffalo...
This is a firm fixed-price, SBIR Phase II contract awarded by the Defense Health Agency (DHA) to Nushores Biosciences LLC, a small business. The contract, valued at $1,299,999.94, is for the product development and commercialization readiness of a class of ether-based bioresorbable polyurethanes for biomedical applications. The contract has a period of performance through December 20, 2026. This award is part of the DHA's SBIR program and is designated as a total small business set-aside.